Efficacy and safety of a novel synergistic drug candidate, CRx-102, in hand osteoarthritis

OBJECTIVE: The novel synergistic drug candidate CRx-102 comprises dipyridamole and low dose prednisolone and is in clinical development for the treatment of immunoinflammatory diseases. The purpose of this clinical study was to examine the efficacy and safety of CRx-102 in patients with hand osteoar...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Kvien, T K, Fjeld, E, Slatkowsky-Christensen, B, Nichols, M, Zhang, Y, Prøven, A, Mikkelsen, K, Palm, Ø, Borisy, A A, Lessem, J
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2008
Teme:
Extended Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2564788/
https://ncbi.nlm.nih.gov/pubmed/17962237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2007.074401
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki